Pjp3'2003 Symp.Vp:Corelventura
Total Page:16
File Type:pdf, Size:1020Kb
THIRTY YEARS OF COOPERATION BETWEEN GERMAN AND POLISH PHARMACOLOGISTS. NEW PERSPECTIVES IN THE COMMON EUROPE Pharmacology is only just a small part of the science and scientists are a small fraction of each country. However, the example of joint activities of Polish and German pharmacologists shows that making new human relationships is possible. Jerzy Maj n Official Symposium of the Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie and of the Polish Pharmacological Society n Białowieża, September 18–21, 2003 ENDOGENOUS 1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES POSSESS ANTIDOPAMINERGIC AND NEUROPROTECTIVE ACTIVITY IN RAT BRAIN Lucyna Antkiewicz-Michaluk, Jerzy Michaluk, Irena Romañska, Andrzej Bojarski, Jerzy Vetulani Department of Biochemistry, Institute of Pharmacology, Polish Academy of Sciences, Smêtna 12, PL 31-343 Kraków, Poland 1,2,3,4-Tetrahydroisoquinoline derivatives (TIQs) on both pathways of DA catabolism, inhibition of are present both in man and animal brain, and may MAOB-dependent N-oxidation, and acceleration at play important physiological role. However, the least twice the COMT-dependent O-methylation. earlier studies have suggested neurotoxic effect of Such an effect on DA catabolism may reduce the TIQs, resulting from their similarity to 1-methyl- generation of free radicals accompanying this pro- 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and cess. We also investigated whether 1MeTIQ exerts ability to form tetrahydroisoquinolinium ions, ana- a protective action against the degeneration of do- logous to 1-methyl-4-phenylpyridinium ion (MPP+), paminergic terminals induced by neurotoxic herbi- and in fact experimental parkinsonism was induced cide – rotenone (7 days, 10 mg/kg sc) in rat brain. by TIQs (TIQ, salsolinol, 1-BnTIQ) in rodents and We have found that repeated but not single admini- marmosets [1, 2]. Another TIQ derivative – 1-me- stration of rotenone causing abnormalities in ge- thyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ) – neral behavior of rats, produced considerable mor- was regarded as a neuroprotectant antagonizing the tality, and dramatic increases in DA metabolism, parkinsonism-like behavioral abnormalities in mice which may be ascribed to an increase in the oxida- [3]. In our study, we investigated the acute and tive pathways (strong increase in DOPAC level), chronic effect of TIQs in the behavioral and bio- and 1MeTIQ completely antagonized these effects. chemical experiments. In summary, we have demonstrated that TIQs The results have shown that all investigated tet- are the ideal candidates for natural regulators of rahydroisoquinoline compounds: TIQ, salsolinol, DA system, that would prevent its hyperactivity, 1BnTIQ and 1-MeTIQ administered to rodents and additionally the results have shown neuropro- (25–100 mg/kg ip) antagonized effectively in dose- tective activity of 1MeTIQ against rotenone-indu- related manner the behavioral action (locomotor ced neurodegeneration. hyperactivity) induced by dopamine (DA) agonists: apomorphine and amphetamine (0.25 and 0.5 mg/kg REFERENCES sc). Biochemical experiments have shown the dif- 1. ferences in effects of two tetrahydroisoquinolines: Antkiewicz-Michaluk L., Michaluk J., Mokrosz M., Romañska I., Lorenc-Koci E., Ohta S., Vetulani J.: 1MeTIQ and 1BnTIQ on DA metabolism and ca- Different action on dopamine catabolic pathways of tabolism which would explain their neuroprotec- two endogenous 1,2,3,4-tetrahydroisoquinolines with tive and neurotoxic ability. 1MeTIQ did not change similar antidopaminergic properties. J. Neurochem., the DA concentration either after acute or chronic 2001, 78, 100–108. treatment in any investigated structures (substantia 2. Nagatsu T., Yoshida M.: An endogenous substance of nigra, striatum, nucleus accumbens). In contrast, the brain, tetrahydroisoquinoline, produces parkinson- ism in primates with decreased dopamine, tyrosine hy- 1BnTIQ produced a dramatic fall of DA level in droxylase and biopterin in the nigrostriatal region. the striatum and nucleus accumbens with the in- Neurosci. Lett., 1988, 87, 178–182. crease in homovanillic acid level (HVA), which in- 3. Tasaki Y., Makino Y., Ohta S., Hirobe M.: 1-Methyl- dicates a massive release of DA from the nerve 1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl- endings. This effect may be the cause of neurotoxic 4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, pre- properties of 1BnTIQ. The neuroprotective action vents parkinsonism-like behavior abnormalities. J. Neu- of 1MeTIQ may be explained by its different action rochem., 1991, 57, 1940–1943. ISSN 1230-6002 479 Abstracts of Symposium EFFECTS OF FELBAMATE AND ITS COMBINATIONS WITH CONVENTIONAL ANTIEPILEPTIC DRUGS IN AMYGDALA-KINDLED RATS Kinga K. Borowicz, Stanis³aw J. Czuczwar Department of Pathophysiology, Medical University, Jaczewskiego 8, PL 20-090 Lublin, Poland Felbamate modified behavioral and electro- doses of valproate, phenobarbital, diphenylhydan- graphic correlates of kindled seizures in rats. In de- toin or clonazepam did not express any protective tail, when applied at the dose of 5 or 10 mg/kg, action. The concomitant treatment of felbamate felbamate significantly increased afterdischarge with conventional antiepileptics did not induce threshold, shortened seizure and afterdischarge du- any significant motor impairment in the chimney rations, but remained without effect on seizure se- test or memory deficit in the passive avoidance verity. Furthermore, the combination of felbamate task. A pharmacokinetic interaction between felba- (2.5 mg/kg) with carbamazepine (7.5 mg/kg; both mate and carbamazepine can be excluded, at least drugs at their subeffective doses), reduced the sei- at the level of plasma and brain concentrations. The zure severity and afterdischarge duration of kindled antiseizure efficacy of felbamate/carbamazepine seizures. In respect of afterdischarge duration, the combination evaluated in the present study may antiseizure potency of the felbamate/carbamaze- justify its usage as an add-on therapy, being worth pine combination was comparable to that of carba- considering particularly in cases of multiple drug- mazepine alone administered at 10 mg/kg. Neither resistant partial epilepsy. carbamazepine (7.5 and 10 mg/kg) nor felbamate (2.5–10 mg/kg) affected seizure severity, whereas REFERENCES combined treatment of felbamate (2.5 mg/kg) with 1. Borowicz K.K., Stasiuk G., Teter J., Kleinrok Z., carbamazepine (7.5 mg/kg) led to significant re- G¹sior M., Czuczwar S.J.: Low propensity of conven- duction of seizure severity from 5th to 3rd stage of tional antiepileptic drugs for interaction with felba- Racine’s scale. Among conventional antiepileptic mate against maximal electroshock-induced seizures in mice. J. Neural Transm., 2000, 107, 733–743. drugs tested in this study, only valproate (100 2. Ebert U., Reissmüller E., Löscher W.: The new antie- mg/kg) and clonazepam (0.1 mg/kg) exerted simi- pileptic drugs lamotrigine and felbamate are effective lar action on seizure severity. However, the combi- in phenytoin-resistant kindled rats. Neuropharmacolo- nations of felbamate (2.5 mg/kg) with subeffective gy, 2000, 39, 1893–1903. EFFECT OF CYCLOOXYGENASE AND NITRIC OXIDE SYNTHASE INHIBITORS ON ANTINOCICEPTIVE ACTION OF ACETAMINOPHEN Magdalena Bujalska Department of Pharmacodynamics, Medical University, Krakowskie Przedmiecie 26/28, PL 00-927 Warszawa, Poland Acetaminophen (ACETA), an active metabolite from those of aspirin (ASA), this drug has widely of phenacetin, is a commonly used antinocicep- replaced ASA and other salicylates in the treatment tive/antypyretic drug. Although its antinociceptive of mild to moderate pain in conditions not associ- and antipyretic activities do not differ markedly ated with inflammatory processes such as head- 480 Pol. J. Pharmacol., 2003, 55, 479–518 THIRTY YEARS OF COOPERATION BETWEEN GERMAN AND POLISH PHARMACOLOGISTS ache, toothache and dysmenorrhoea. A lack of anti- hibitor preferentially acting on COX-1, as well as inflammatory activity can be attributed to the fact nimesulide (NIM) and celecoxib (CECOX), prefer- that ACETA does not influence or does not sub- ential and selective inhibitor of COX-2 respec- stantially inhibit the activity of cyclooxygenases tively, administered, icv or peripherally almost (COXs) in peripheral tissues [1, 2]. completely blocked the antinociceptive effect of In spite of the numerous investigations, the ACETA in Randall-Selitto method. On the other mechanism of ACETA action is still poorly defined hand, pretreatment with NSAIDs it initially in- and has been not satisfactorily explained. creased and then attenuated the ACETA antinoci- It was, therefore, of interest to investigate the ception. Yohimbine did not modify antinociceptive effects of COX and nitric oxide synthase (NOS) in- action of ACETA when administered alone. How- hibitors on the antinociceptive activity of ACETA. ever, yohimbine decreased the nociceptive threshold Effect of yohimbine, an a2-adrenergic receptor an- increased by co-administration of IND and ACETA, tagonist, was also checked. NIM and ACETA as well as CECOX and ACETA Intrathecal (it), intracerebroventricular (icv)or in Randall-Selitto model. peripheral pretreatment with L-G-nitro-L-arginine The results of this study indicate that both COX (L-NO-Arg), a non-selective inhibitor of NOS ac- and nNOS systems are involved in the antinocicep- tivity, as well as with 7-nitroindazole (7-NI), an se- tive activity of ACETA. lective inhibitor of neuronal NOS,